ResMed company profile
Company profile
ResMed has 11,370 employees and is headquartered in San Diego, United States.
Founded in 1989 and based in San Diego, California, ResMed develops digital health and cloud-connected medical devices, with a focus on sleep apnea. Its sleep recorders, such as ApneaLink Air and NightOwl, are used in sleep clinics, hospitals and at home, while AirView and the myAir application allow remote monitoring of device settings and patient therapy. Through its Residential Care Software segment, the company supplies software to home medical equipment and pharmacy providers, home health and hospice agencies, and skilled nursing and senior living operators, including Brightree, HEALTHCAREfirst, MatrixCare and MEDIFOX DAN. It serves customers in the United States and internationally.
In the fiscal year ended June 2026, ResMed reported revenue of 5.7 billion US dollars, up 9.9% from the previous year, and net profit of 1.5 billion US dollars. The United States accounted for 63% of revenue and non-US markets for 37%. The company employed 11,370 people, and its headquarters are in San Diego.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Headquarters
- 9001 Spectrum Center Boulevard, 92123, San Diego
- Employees
- 11,370
- Chief executive
- Michael Farrell
- Founded
- 1989
- Fiscal year
- July - June
- Listing
- RMD · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US7611521078
- Website
- resmed.com
ResMed and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| ResMedRMD | United States | $33.5B | 11,370 | 34.0% | 21.8 |
| West Pharmaceutical ServicesWST | United States | $29.1B | 10,000 | 22.9% | 46.9 |
| MedlineMDLN | United States | $42.57B | 45,000 | 5.0% | 40.2 |
| Becton, DickinsonBDX | United States | $58.96B | 60,000 | 15.7% | 42.8 |
| SolventumSOLV | United States | $15.07B | 20,584 | 5.9% | 99.6 |
| Baxter InternationalBAX | United States | $13.41B | 37,500 | 7.6% | — |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
